COVID-19
Moderna’s COVID-19 Vaccine Could Be Granted FDA Emergency Use Authorization in December, Says CEO
Moderna, Inc.’s (Cambridge, MA, USA) experimental COVID-19 vaccine could be granted Emergency Use Authorization (EUA) by the US Food and Drug Administration (FDA) in December based...
Latest COVID-19 News
- World’s First Human Challenge COVID-19 Study to Infect Healthy Young Volunteers with SARS-CoV-2 Virus
- ThermoGenesis’ Breakthrough Lateral Flow Immunoassay Test Reader to Help Track Antibody Response of COVID-19 Vaccine Recipients
- Novel T Cell Targets Found in Recovering COVID-19 Patients to Enable Development of Next-Generation Vaccines
- Saline Oral Rinse COVID-19 RT-PCR Test Could Be a Game-Changer for Coronavirus Testing
- Breakthrough Study Identifies What Makes SARS-CoV-2 Highly Infectious and Spread Rapidly in Human Cells
- New Testing Process Could Make It Faster, Easier, And Less Expensive to Measure COVID-19 Antibody Levels
- New Lab Testing Procedure Specifically Identifies SARS-CoV-2 Neutralizing Antibodies
- New Serology Assay Accelerates COVID-19 Research through Rapid Characterization of Immune Response to SARS-CoV-2 Antigens
- Engineered COVID-19 Antibody Enables Extremely Rapid Identification of SARS-CoV-2 in Nasal Mucus, Saliva, and Blood
- New Rapid Lateral Flow Antigen COVID-19 Testing Platform Processes 200-300 People Each Hour and Reports Results in 15 Minutes (C)
- Novel COVID-19 Immunity Test Predicts Both Infection Risk in Healthy Individuals and Disease Severity in Patients
- Pfizer to Seek FDA Emergency Use Authorization for Its COVID-19 Vaccine in Late November
- Researchers Find Existing Medications That Could Speed Recovery of COVID-19 Patients
- Gilead’s Remdesivir Has Little or No Effect on Survival of COVID-19 Patients, Finds WHO’s Solidarity Trial
- COVID-19 Antibody Cocktail Won’t Be Widely Available Due to Limited Production Capacity, Says Roche
- SARS-CoV-2 Neutralizing Antibodies Fade Quickly in Recovering COVID-19 Patients After Symptoms Subside
- World’s Simplest High-Throughput RT-PCR Test for COVID-19 Could Increase Testing Capacity by Millions per Week
- New Blood Test Accurately Predicts COVID-19 Patients at Risk of Severe Infection
- At Least One Effective COVID-19 Vaccine to Be Available by 2021, But Only in Limited Quantities, Says WHO
- Extremely Rapid COVID-19 Diagnostic Test Detects and Identifies SARS-CoV-2 Virus in Under Five Minutes
- New 1-Minute COVID-19 Antibody Test Uses Innovative Flow-Through Technology to Deliver Results
- Siemens Launches New Rapid COVID-19 Antigen Test for Detection of SARS-CoV-2
- New COVID-19 Test Uses Nanotube-Based Electrochemical Biosensor for Rapid Detection of SARS-CoV-2 Virus in 30 Seconds
- COVID-19 Vaccine May Not Need to Achieve Highest Possible RBD-S Antibody Levels, Say Researchers
- World's First Paper-Based COVID-19 Test Could Be Game-Changer for Coronavirus Testing
- Eli Lilly Pauses Trial of Combination Antibody Treatment for COVID-19 Due to Safety Concerns
- Study by Scientists Who Discovered SARS Could Lead to Development of COVID-19 Treatment Inspired by Own Immune System (B)
- Unique COVID-19 Vaccine Uses Modified Bovine Adenovirus to Provide Significantly Higher Levels of Immunity (B)
- Intranasal COVID-19 Vaccine Candidate Shows Potent Immune Responses in Extensive Preclinical Tests